Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
Clinical trial NCT00969306 · TERMINATED
Trial details
- NCT number
- NCT00969306
- Sponsor
- Maastricht Radiation Oncology
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.